Global Life Sciences search specialist, Coulter Partners is delighted to announce the opening of a new office in the Belgian capital and six key appointments. Penny Sadler strengthens the company’s rapidly growing Medtech expertise as Client Partner in Brussels, while Dr Nanna Soni (PhD DIC) is appointed Director in London to the R&D centre of expertise. Please see Press Release for full details.
Hertfordshire Local Enterprise Partnership is to invest £1.2m into Stevenage Bioscience Catalyst (SBC) to help grow a world-class cell and gene therapy cluster.
The £1.2m Local Growth Fund investment will provide much-needed temporary accommodation for growing cell and gene therapy companies, strengthening the UK’s sectorial advantage and Hertfordshire’s position within the Oxford-London-Cambridge golden research triangle.
Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that its Chief Executive Officer, Dr Sarah Howell, will present at The sixth China Healthcare Summit, held from 18th to 20th November at the Jing An Shangri-La, Shanghai, China.
• Animal model operations to be transferred to Envigo ownership
• Divestment in line with Horizon’s corporate strategy to focus on its core markets
• Envigo, a leading global research model supplier, enters the gene-edited research model field with the addition of Horizon’s business
• Horizon and Envigo to collaborate on providing CRISPR screening services
- Transformative acquisition creates global cell and gene therapy manufacturing services platform for both clinical and commercial products
- EW Healthcare Partners and its co-investors provide the financing for the transaction
Repositive is unveiling molecular search functionality for its Cancer Models Platform today at ELRIG Drug Discovery. The first version of this innovative feature enables pharma and biotech scientists to search Repositive’s cancer model directory by their gene of interest and explore different mutations available to ensure they source a cancer model with the right molecular profile for their preclinical study.